Clinical trial
CASCADE: A Single-Arm, Open-Label Clinical Phase II Trial of the Safety and Immunogenicity of PDS0101 in People Living With HIV
NCT07090174 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CASCADE: A Single-Arm, Open-Label Clinical Phase II Trial of the Safety and Immunogenicity of PDS0101 in People Living With HIV
- Lead sponsor
- University of California, San Diego
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- April 30, 2026
- Completion date
- December 31, 2026
- Enrollment
- 0 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
anal cancer, cervical cancer, hiv (human immunodeficiency virus), hpv 16 infection, hpv associated cancers